Yadlin Ventures

Consulting services focused on Healthcare, Therapeutics, Diagnostics, Life Science Tools & Tech. A scientist by training, Dina’s career started in life science as a graduate researcher at the Broad Institute and a postdoctoral fellow at Amgen. She gained hands-on therapeutic development experience from small-molecule screening to biologics process development and performed original research resulting in authorship of over a dozen peer-reviewed publications. Stepping away from the bench, Dina stepped into a corporate and business development role at NanoString, reporting to SVP of BD, and was responsible for strategic planning, streamlining of business processes and identifying biopharma collaboration opportunities for the companion diagnostics business unit. In 2019, she founded Yadlin Ventures, LLC, to offer consulting services focused on emerging healthcare products, therapeutics, diagnostics and life science tools and tech. Over the last 5 years, she analyzed market landscapes and competitive dynamics to inform clients’ investment, corporate and commercial strategies. Yadlin Ventures consulting services include assessments of therapeutic modalities and indications, biopharma pipelines, clinical trials, emerging tools and technologies, market trends, business models and commercial opportunities. Dina holds a BA in biochemistry from UC Berkeley, a PhD in molecular biology from Harvard University and an MBA from UW Michael G. Foster School of Business. Dina is passionate about extracting insights from data, evidence-based wellness and the PNW lifestyle with her 3 kids and 2 dogs.